文献速递心律失常

75岁及以上老年房颤患者的管理:JACC最新综述

Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

随着人口老龄化,房颤患病率增加,老年(≥75岁)患者治疗相关并发症也显著增加。该人群卒中、出血和死亡风险高,晕厥和跌倒相关损伤是不处方口服抗凝药的最常见原因。直接口服抗凝药较华法林的优势扩展至老年人群,导管消融、起搏器植入/房室结消融及左心耳封堵在合适选择的病例中可能有用,但老年人在临床试验中代表性不足。

要点

  • 老年房颤患者卒中、出血和死亡风险高,晕厥和跌倒常导致口服抗凝药未处方。
  • 直接口服抗凝药较华法林的优势扩展至老年人群,卒中预防是关键。
  • 导管消融、起搏器/房室结消融及左心耳封堵在合适选择的老年病例中可能有用。

核心结论

  • 老年房颤患者管理需综合评估卒中、出血和跌倒风险,直接口服抗凝药较华法林的优势扩展至该人群。

研究设计与样本

  • 本文为JACC最新综述,聚焦≥75岁老年房颤患者的管理。

主要发现

  • 老年房颤患者卒中、出血和死亡风险高,晕厥和跌倒相关损伤是不处方口服抗凝药的最常见原因。
  • 与抗心律失常药物联用时,口服抗凝药在老年人中更常见晕厥和跌倒相关损伤。
  • 地高辛可用于控制心室率,但与死亡率增加相关限制其使用。

临床怎么用

  • 卒中预防是老年房颤管理的核心,直接口服抗凝药优于华法林。
  • 对于合适选择的老年患者,可考虑导管消融、起搏器植入/房室结消融及左心耳封堵。

局限性

  • 老年人在临床试验中代表性不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of atrial fibrillation (AF) is increasing as the population ages. AF treatment-related complications also increase markedly in older adults (defined as ≥75 years of age for this review). The older AF population has a high risk of stroke, bleeding, and death. Syncope and fall-related injuries are the most common reasons for nonprescription of oral anticoagulation (OAC), and are more common in older adults when OACs are used with antiarrhythmic drugs. Digoxin may be useful for rate control, but associations with increased mortality limit its use. Beyond rate and rhythm control considerations, stroke prophylaxis is critical to AF management, and the benefits of direct OACs, compared with warfarin, extend to older adults. Invasive procedures such as AF catheter ablation, pacemaker implantation/atrioventricular junction ablation, and left atrial appendage occlusion may be useful in appropriately selected cases. However, older adults have generally been under-represented in clinical trials.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Volgman, Nair, Lyubarova, et al. Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 35027110. doi:10.1016/j.jacc.2021.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。